UBS Group’s Intelligent Bio Solutions INBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $516 | Sell |
300
-872
| -74% | -$1.5K | ﹤0.01% | 8480 |
|
|
2025
Q1 | $1.69K | Sell |
1,172
-1,731
| -60% | -$2.49K | ﹤0.01% | 8146 |
|
|
2024
Q4 | $4.06K | Buy |
2,903
+1,352
| +87% | +$1.89K | ﹤0.01% | 7549 |
|
|
2024
Q3 | $2.68K | Sell |
1,551
-6,769
| -81% | -$11.7K | ﹤0.01% | 7176 |
|
|
2024
Q2 | $16K | Buy |
8,320
+7,972
| +2,291% | +$15.3K | ﹤0.01% | 6299 |
|
|
2024
Q1 | $1.47K | Buy |
+348
| New | +$1.47K | ﹤0.01% | 6952 |
|
|
2023
Q2 | – | Sell |
-51
| Closed | -$1.78K | – | 8082 |
|
|
2023
Q1 | $1.78K | Buy |
51
+6
| +13% | +$209 | ﹤0.01% | 7548 |
|
|
2022
Q4 | $2.15K | Buy |
45
+42
| +1,400% | +$2.01K | ﹤0.01% | 8527 |
|
|
2022
Q3 | $0 | Sell |
3
-50
| -94% | – | ﹤0.01% | 9430 |
|
|
2022
Q2 | $8K | Buy |
53
+6
| +13% | +$906 | ﹤0.01% | 7272 |
|
|
2022
Q1 | $9K | Buy |
47
+9
| +24% | +$1.72K | ﹤0.01% | 7495 |
|
|
2021
Q4 | $13K | Buy |
38
+12
| +46% | +$4.11K | ﹤0.01% | 7331 |
|
|
2021
Q3 | $16K | Buy |
+26
| New | +$16K | ﹤0.01% | 6279 |
|
|
2021
Q2 | – | Sell |
-6
| Closed | -$9K | – | 8402 |
|
|
2021
Q1 | $9K | Buy |
6
+2
| +50% | +$3K | ﹤0.01% | 6975 |
|
|
2020
Q4 | $8K | Buy |
+4
| New | +$8K | ﹤0.01% | 6595 |
|